Cannex Capital closes acquisition of Pure Ratios and provides 4Front transaction update

June 11, 2019
Acquisition will add innovative wellness brand combining cannabis and holistic medicine, including a premium hemp-derived CBD product portfolio

VANCOUVER, BC, June 11, 2019 - Cannex Capital Holdings Inc. (CSE: CNNX) (OTCQX: CNXXF) (“Cannex” or the “Company”) is pleased to announce that it has closed its previously announced acquisition of 100% of San Diego, California-based Pure Ratios Holdings, Inc. (“Pure Ratios”) in a cash and stock transaction (the “Transaction”).

  • Pure Ratios has authentic positioning in the cannabinoid wellness segment with a solid foundation in California;
  • Pure Ratios has expertise integrating cannabinoids into a variety of form factors including a patented 96-hour transdermal patch, its best-selling product;
  • Pure Ratios co-founder and CEO, Chad Conner, is an experienced practitioner of holistic medicine and a recognized public speaker on cannabis and alternative approaches to wellness.

Click here to read full press release


Cannex is partnering with Cannabis Europa this June in London, UK
June 24-25th - Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe.
Buy tickets here
Cannex presenting at MJMicro Conference June 25th in NY
MjMicro is an invitational networking forum that unites publicly traded cannabis companies led by seasoned executives with next-level, high-net-worth investors.
Request invite here
Cannex presenting and partnering with IC3 in London
MN and Prohibition Partners will co-host the first annual Institutional Capital & Cannabis Conference Europe (IC3 Europe), June 26, in London.
Buy tickets here